Keywords: mgi, deal, upjohn, pharma, granted, canada, canadian

MGI Deal With Upjohn

Article | 05 December 1994

Print This

- MGI Pharma has granted Upjohn Canada the Canadian rights to Salagen Tablets (pilocarpine), which was approved in the USA for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in